GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sprint Bioscience SPRINT.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

4.05

+1.25%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Sprint Bioscience annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2021FY2020
RevenueSEK 167.2mSEK 65.6mSEK 50.5mSEK 35.1mSEK 16.9m
Operating incomeSEK 97.3m−SEK 19.7m−SEK 845,000−SEK 25.5m−SEK 38.8m
Net incomeSEK 91.7m−SEK 18.3m−SEK 438,000−SEK 25.4m−SEK 46.2m
Free cash flowSEK 83.4m−SEK 24.7mSEK 20.4m−SEK 42.8m−SEK 34.9m
Total assetsSEK 136.7mSEK 42.1mSEK 62.4mSEK 79.1mSEK 33.4m
Shareholders' equitySEK 119.2mSEK 9.3mSEK 27.8mSEK 70.5mSEK 9.1m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.